Hoth Therapeutics Inc (HOTH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access HOTH Annual Balance Sheets →
The data below summarizes Hoth Therapeutics Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent7.89
Cash & Short-term Investments7.00
Deferred Offering Costs DE0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.98
Total Current Assets8.58
Long-term investments0.04
Deferred, Prepaid and Other Assets, Noncurrent1.66
Other Assets, Noncurrent0.00
Crypto Asset Fair Value Current-
Operating Lease Right Of Use Asset-
Total Assets9.58
Liabilities
Accounts Payable, Current AC1.00
Accrued Liabilities, Current AC0.38
Other Liabilities, Current0.00
Total Current Liabilities1.38
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Total Liabilities1.38
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock87.59
Retained Earnings / Accumulated Deficit-79.41
Accumulated Other Comprehensive Income0.01
Other Equity0.01
Common Stockholder's Equity8.20
Total Stockholder's Equity8.20
Liabilities & Stockholder's Equity9.58
4 historic quarters locked

Sign in to unlock the full Hoth Therapeutics Inc balance sheet history.

About Rocket One Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-090048

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.